Notice of the 2025 Annual Shareholders' Meeting
Renhe Pharmaceutical Co., Ltd. and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Important Content Reminder:
- The 2025 Annual Shareholders' Meeting will be held on June 26, 2026.
- The record date for shareholders is June 18, 2026.
The ninth extraordinary meeting of the tenth Board of Directors of Renhe Pharmaceutical Co., Ltd. has approved the proposal to convene the 2025 Annual Shareholders' Meeting. The meeting is scheduled as follows:
Basic Information of the Meeting
- Meeting Session: 2025 Annual Shareholders' Meeting
- Meeting Convener: The Board of Directors of the Company
- Legality and Compliance of the Meeting: The convening of this shareholders' meeting complies with the relevant provisions of the Company Law, Stock Listing Rules, and Articles of Association, and does not require approval from relevant departments or the fulfillment of necessary procedures.
- Record Date: June 18, 2026
- Meeting Time:
- On-site Meeting: June 26, 2026, at 14:00
- Online Voting Time: Through the Shenzhen Stock Exchange trading system from 9:15-9:25 and 9:30-11:30, and from 13:00-15:00 on June 26, 2026; through the Shenzhen Stock Exchange internet voting system from 9:15 to 15:00 on June 26, 2026.
- Meeting Method: The shareholders' meeting will be conducted through a combination of on-site voting and online voting.
- On-site Voting: Shareholders may attend the meeting in person or authorize others to attend on their behalf.
- Online Voting: The Company will provide an online voting platform through the Shenzhen Stock Exchange trading system and internet voting system (http://wltp.cninfo.com.cn) for all shareholders to exercise their voting rights during the specified online voting times.
- Shareholders may only choose one voting method. In case of duplicate voting on the same voting right, the result of the first vote will prevail.
Attendees
- All shareholders registered with China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, by 15:00 on June 18, 2026; shareholders unable to attend the meeting in person may authorize an agent to attend and vote on their behalf, and the agent does not need to be a shareholder of the Company.
- Company directors and senior management.
- Lawyers hired by the Company.
On-site Meeting Location
Conference Room, No. 36 Renhe Road, Zhangshu City, Jiangxi Province.
Matters for Discussion at the Meeting
- Proposal Code Example Table
Proposal Code Proposal Name Remarks 100 Total Proposal: All proposals except cumulative voting proposals √ 1.00 Proposal on the 2025 Annual Board Work Report √ 2.00 Proposal on the 2025 Annual Report and Summary √ 3.00 Proposal on the 2025 Annual Financial Settlement Report √ 4.00 Proposal on the 2025 Annual Profit Distribution Plan √ 5.00 Proposal on the Reappointment of the Audit Firm for 2026 √ 6.00 Proposal on Authorizing the Board to Formulate the 2026 Mid-term Dividend Plan √ 7.00 Proposal on Establishing the Compensation Management System for Directors and Senior Management √ 8.00 Proposal on Confirming the 2025 Compensation for Directors and Senior Management and the 2026 Compensation Plan √ 9.00 Proposal on Using Own Funds for Investment and Financial Management √